• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

终末期癌症姑息治疗的间接成本:一项基于真实生活的纵向登记和问卷调查研究。

The indirect costs of palliative care in end-stage cancer: A real-life longitudinal register- and questionnaire-based study.

机构信息

1 Tuusula Health Care Centre, Tuusula, Finland.

2 Department of Public Health, University of Helsinki, Helsinki, Finland.

出版信息

Palliat Med. 2018 Feb;32(2):493-499. doi: 10.1177/0269216317729789. Epub 2017 Sep 12.

DOI:10.1177/0269216317729789
PMID:28895471
Abstract

BACKGROUND

Palliative care needs are increasing as more people are dying from incurable diseases. Healthcare costs have been reported to be highest during the last year of life, but studies on the actual costs of palliative care are scarce.

AIM

To explore the resource use and costs of palliative care among end-stage breast, colorectal and prostate cancer patients after termination of life-prolonging oncological treatments, that is, during the palliative care period.

DESIGN

A real-life longitudinal register- and questionnaire-based study of cancer patients' resource use and costs.

PARTICIPANTS

In total, 70 patients in palliative care with no ongoing oncological treatments were recruited from the Helsinki University Hospital or from the local hospice. Healthcare costs, productivity costs and informal care costs were included.

RESULTS

The mean duration of the palliative care period was 179 days. The healthcare cost accounted for 55%, informal care for 27% and productivity costs for 18% of the total costs. The last 2 weeks of life contributed to 37% of the healthcare cost. The costs of the palliative care period were higher in patients living alone, which was mostly caused by inpatient care ( p = 0.018).

CONCLUSION

The 45% share of indirect costs is substantial in end-of-life care. The healthcare costs increase towards death, which is especially true of patients living alone. This highlights the significant role of caregivers. More attention should be paid to home care and caregiver support to reduce inpatient care needs and control the costs of end-of-life care.

摘要

背景

随着越来越多的人死于绝症,姑息治疗的需求正在增加。据报道,医疗保健费用在生命的最后一年最高,但关于姑息治疗实际成本的研究很少。

目的

探讨在终止延长生命的肿瘤治疗后,即姑息治疗期间,终末期乳腺癌、结直肠癌和前列腺癌患者的姑息治疗资源利用和成本。

设计

一项基于登记和问卷调查的癌症患者资源利用和成本的真实纵向研究。

参与者

共招募了 70 名来自赫尔辛基大学医院或当地临终关怀机构的无持续肿瘤治疗的姑息治疗患者。包括医疗保健费用、生产力成本和非正式护理成本。

结果

姑息治疗期的平均持续时间为 179 天。医疗保健费用占 55%,非正式护理占 27%,生产力成本占 18%。生命的最后 2 周贡献了 37%的医疗保健费用。独居患者的姑息治疗期费用较高,这主要是由于住院治疗(p=0.018)。

结论

在生命末期护理中,间接成本的 45%占比相当大。医疗保健费用随着死亡而增加,独居患者的情况更是如此。这突出了照顾者的重要作用。应更多关注家庭护理和照顾者支持,以减少住院护理需求并控制生命末期护理的成本。

相似文献

1
The indirect costs of palliative care in end-stage cancer: A real-life longitudinal register- and questionnaire-based study.终末期癌症姑息治疗的间接成本:一项基于真实生活的纵向登记和问卷调查研究。
Palliat Med. 2018 Feb;32(2):493-499. doi: 10.1177/0269216317729789. Epub 2017 Sep 12.
2
Societal costs of home and hospital end-of-life care for palliative care patients in Ontario, Canada.加拿大安大略省姑息治疗患者居家和医院临终关怀的社会成本。
Health Soc Care Community. 2015 Nov;23(6):605-18. doi: 10.1111/hsc.12170. Epub 2014 Dec 2.
3
Costs of formal and informal care in the last year of life for patients in receipt of specialist palliative care.接受专科姑息治疗患者生命最后一年的正规和非正规护理费用。
Palliat Med. 2017 Apr;31(4):356-368. doi: 10.1177/0269216316686277. Epub 2017 Jan 17.
4
Cost analysis of palliative care for terminally ill cancer patients in the UK after switching from weak to strong opioids. Palliative Care Advisory Committee.英国晚期癌症患者从弱阿片类药物转换为强阿片类药物后的姑息治疗成本分析。姑息治疗咨询委员会。
Pharmacoeconomics. 1998 Sep;14(3):285-97. doi: 10.2165/00019053-199814030-00005.
5
Impact of palliative home care support on the quality and costs of care at the end of life: a population-level matched cohort study.姑息治疗居家支持对终末期照护质量和成本的影响:基于人群的匹配队列研究。
BMJ Open. 2019 Jan 21;9(1):e025180. doi: 10.1136/bmjopen-2018-025180.
6
The trajectory of palliative care costs over the last 5 months of life: a Canadian longitudinal study.生命最后 5 个月的姑息治疗成本轨迹:一项加拿大纵向研究。
Palliat Med. 2010 Sep;24(6):630-40. doi: 10.1177/0269216310368453. Epub 2010 May 25.
7
The magnitude, share and determinants of unpaid care costs for home-based palliative care service provision in Toronto, Canada.加拿大多伦多居家姑息治疗服务提供中无偿护理成本的规模、占比及影响因素。
Health Soc Care Community. 2014 Jan;22(1):30-9. doi: 10.1111/hsc.12058. Epub 2013 Jun 12.
8
Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.不同种族文化群体成年癌症患者的姑息治疗体验:一项定性系统评价方案
JBI Database System Rev Implement Rep. 2015 Jan;13(1):99-111. doi: 10.11124/jbisrir-2015-1809.
9
Geographical disparities in treatment and health care costs for end-of-life cancer patients in China: a retrospective study.中国终末期癌症患者治疗和医疗费用的地域差异:一项回顾性研究。
BMC Cancer. 2019 Jan 8;19(1):39. doi: 10.1186/s12885-018-5237-1.
10
Costs of colorectal cancer in different states of the disease.疾病不同阶段的结直肠癌成本。
Acta Oncol. 2015 Apr;54(4):454-62. doi: 10.3109/0284186X.2014.985797. Epub 2014 Dec 18.

引用本文的文献

1
Cost-effectiveness of expanding the target population of biennial screening for breast cancer from ages 50-69 to 45 and/or 74: A cohort modelling study in the Finnish setting.将乳腺癌两年一次筛查的目标人群从50至69岁扩大到45岁和/或74岁的成本效益:芬兰背景下的队列建模研究
Health Econ Rev. 2025 Apr 11;15(1):35. doi: 10.1186/s13561-025-00628-5.
2
Methodologies and characteristics of studies investigating the cost of the palliative phase of cancer: a systematic review.研究癌症姑息治疗阶段成本的方法与特点:一项系统综述
Support Care Cancer. 2025 Jan 28;33(2):126. doi: 10.1007/s00520-025-09150-0.
3
Costs of Palliative Care in Oncological and Non-Oncological Patients with Different Types of Ambulatory-Based Attention: Cost-Study Protocol.
不同类型门诊护理的肿瘤和非肿瘤患者姑息治疗成本:成本研究方案
Diseases. 2024 Oct 5;12(10):243. doi: 10.3390/diseases12100243.
4
Systematic Review of the Cost-Effectiveness of Home-Based Palliative Care Interventions in Patients with Cancer: A Critical Analysis.癌症患者居家姑息治疗干预措施成本效益的系统评价:批判性分析
Cancer Manag Res. 2024 Sep 6;16:1155-1174. doi: 10.2147/CMAR.S472649. eCollection 2024.
5
Palliative Care Costs in Different Ambulatory-Based Settings: A Systematic Review.不同门诊环境下的姑息治疗成本:系统评价。
Pharmacoeconomics. 2024 Mar;42(3):301-318. doi: 10.1007/s40273-023-01336-w. Epub 2023 Dec 27.
6
Cost-effectiveness model of trastuzumab deruxtecan as second-line treatment in HER2-positive unresectable and/or metastatic breast cancer in Finland.曲妥珠单抗-德鲁替康二线治疗芬兰不可切除和/或转移性 HER2 阳性乳腺癌的成本效果模型。
Eur J Health Econ. 2024 Jun;25(4):689-699. doi: 10.1007/s10198-023-01617-3. Epub 2023 Jul 24.
7
Estimation of the demand for palliative care in non-oncologic patients in Chile.智利非肿瘤患者姑息治疗需求的评估。
BMC Palliat Care. 2023 Jan 12;22(1):5. doi: 10.1186/s12904-022-01122-z.
8
Equity and the financial costs of informal caregiving in palliative care: a critical debate.在姑息治疗中,公平和非正式护理的财务成本:一场批判性辩论。
BMC Palliat Care. 2020 May 19;19(1):71. doi: 10.1186/s12904-020-00577-2.
9
Assessment of Health Care Utilization and Cost of Targeted Drug Delivery and Conventional Medical Management vs Conventional Medical Management Alone for Patients With Cancer-Related Pain.评估癌症相关疼痛患者采用靶向药物输送和常规医疗管理与单纯常规医疗管理相比的医疗利用和成本。
JAMA Netw Open. 2019 Apr 5;2(4):e191549. doi: 10.1001/jamanetworkopen.2019.1549.